X4 Pharmaceuticals, Inc. (XFOR)
NASDAQ: XFOR · Real-Time Price · USD
0.1875
+0.0003 (0.16%)
Apr 25, 2025, 12:35 PM EDT - Market open

X4 Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2016 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
Market Capitalization
3312514012164105
Upgrade
Market Cap Growth
-10.81%-10.81%16.23%87.36%-38.49%-39.22%
Upgrade
Enterprise Value
76857792847
Upgrade
Last Close Price
0.190.730.840.992.296.43
Upgrade
PS Ratio
14.7248.93---34.91
Upgrade
PB Ratio
1.445.652.751.631.001.44
Upgrade
P/TBV Ratio
--4.162.131.372.29
Upgrade
EV/Sales Ratio
2.7526.73---15.63
Upgrade
Debt / Equity Ratio
3.533.531.140.520.620.53
Upgrade
Asset Turnover
0.020.02---0.02
Upgrade
Quick Ratio
3.163.165.025.505.896.66
Upgrade
Current Ratio
3.413.415.345.766.276.97
Upgrade
Return on Equity (ROE)
-102.26%-102.26%-161.67%-135.58%-129.28%-61.51%
Upgrade
Return on Assets (ROA)
-60.18%-60.18%-44.38%-40.36%-39.24%-26.39%
Upgrade
Return on Capital (ROIC)
-84.32%-84.32%-60.58%-50.81%-43.72%-28.42%
Upgrade
Earnings Yield
-120.74%-29.93%-72.12%-77.78%-137.70%-59.33%
Upgrade
FCF Yield
-423.09%-104.89%-68.84%-63.97%-111.04%-57.47%
Upgrade
Buyback Yield / Dilution
-13.08%-13.08%-179.91%-146.71%-28.25%-74.13%
Upgrade
Updated Mar 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q